ECRG4 and Alzheimer disease: We investigated whether the expression levels of C2orf40, HDAC9, and TRAPPC12/TRAPPC12-AS1/ADI1 differed in AD brains compared with non-AD control brains in the publicly available RNS-Seq and microarray datasets (Table 3 and Fig. 2).